Get started
MindMaze Therapeutics Holding SAMindMaze Therapeutics Holding SAMindMaze Therapeutics Holding SA

MindMaze Therapeutics Holding SA

No trades
OverviewFinancialsNewsCommunityTechnicalsSeasonalsETFs

Chart


Full chart

Key stats


Market capitalization
‪163.89 M‬ CHF
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.358 CHF
Net income (FY)
‪−17.12 M‬ CHF
Revenue (FY)
‪8.42 M‬ CHF
Shares float
‪137.77 M‬
Beta (1Y)
−0.35

Employees


Employees (FY)
31
Revenue / Employee (1Y)
‪271.52 K‬ CHF
Net income / Employee (1Y)
‪−552.23 K‬ CHF

About MindMaze Therapeutics Holding SA


Sector
Health Technology
Industry
Biotechnology
CEO
Alexandre Capet
Website
mindmazetherapeutics.com
Headquarters
Geneva
IPO date
Sep 19, 2011
Identifiers
2
ISIN CH1251125998
MindMaze Therapeutics Holding SA engages in the development of AI-powered neurotherapeutics and pharmacological treatments for brain disorders. It focuses on addressing neurological and neuropsychiatric conditions through advanced research, clinical development, and technology-driven solutions. The company is headquartered in Geneva, Switzerland.

Check out other big names from the same industry as MMTX.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

ETFs holding the stock


CHSPI
iShares Core SPI(R) ETF (CH)
Weight
0.01%
Market value
‪339.57 K‬
USD
SPIA
UBS ETF (CH) - SPI (R) Units -CHF acc-
Weight
0.01%
Market value
‪133.29 K‬
USD
SPICHA
UBS ETF (CHF) - UBS Core SPI(R) ETF Anteile CHF dis
Weight
0.01%
Market value
‪133.29 K‬
USD
SPISI
UBS ETF (CH) - UBS SPI(R) ESG ETF Units -CHF acc-
Weight
0.00%
Market value
‪114.40 K‬
USD
SPISID
UBS ETF (CH) - SPI (R) ESG Units -CHF dis-
Weight
0.00%
Market value
‪114.40 K‬
USD

Explore more ETFs 

Frequently Asked Questions


The current price of MMTX is 1.210 CHF — it has increased by 12.66% in the past 24 hours. Watch MindMaze Therapeutics Holding SA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SIX exchange MindMaze Therapeutics Holding SA stocks are traded under the ticker MMTX.
MMTX stock has risen by 1.68% compared to the previous week, the month change is a −42.38% fall, over the last year MindMaze Therapeutics Holding SA has showed a −57.09% decrease.
We've gathered analysts' opinions on MindMaze Therapeutics Holding SA future price: according to them, MMTX price has a max estimate of 3.56 CHF and a min estimate of 3.56 CHF. Watch MMTX chart and read a more detailed MindMaze Therapeutics Holding SA stock forecast: see what analysts think of MindMaze Therapeutics Holding SA and suggest that you do with its stocks.
MMTX reached its all-time high on Dec 15, 2025 with the price of 2.990 CHF, and its all-time low was 0.980 CHF and was reached on Dec 15, 2025. View more price dynamics on MMTX chart.
See other stocks reaching their highest and lowest prices.
MMTX stock is 19.05% volatile and has beta coefficient of −0.35. Track MindMaze Therapeutics Holding SA stock price on the chart and check out the list of the most volatile stocks — is MindMaze Therapeutics Holding SA there?
Today MindMaze Therapeutics Holding SA has the market capitalization of ‪163.89 M‬, it has decreased by −8.19% over the last week.
Yes, you can track MindMaze Therapeutics Holding SA financials in yearly and quarterly reports right on TradingView.
MMTX net income for the last half-year is ‪−4.48 M‬ CHF, while the previous report showed ‪−12.56 M‬ CHF of net income which accounts for 64.35% change. Track more MindMaze Therapeutics Holding SA financial stats to get the full picture.
No, MMTX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Feb 3, 2026, the company has 31 employees. See our rating of the largest employees — is MindMaze Therapeutics Holding SA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MindMaze Therapeutics Holding SA EBITDA is ‪−6.44 M‬ CHF, and current EBITDA margin is −60.69%. See more stats in MindMaze Therapeutics Holding SA financial statements.
Like other stocks, MMTX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MindMaze Therapeutics Holding SA stock right from TradingView charts — choose your broker and connect to your account.